| Serial Number | 97933982 |
| Word Mark | PEPTIDREAM |
| Filing Date | Friday, May 12, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Tuesday, September 24, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Manufacture of synthetic peptides to the order and specification of others; Peptide synthesis for others, namely, manufacture of synthetic peptides to the order and specification of others; Manufacture of pharmaceuticals and chemicals to the order and specification of others; Manufacture of synthetic proteins to the order and specification of others; Amino acid synthesis for others, namely, manufacture of amino acids to the order and specification of others |
| Goods and Services | Synthesized peptides used in drug discovery of various pharmaceuticals directed to different diseases; Chemical preparations used in drug discovery and for pharmaceutical purposes; Central nervous system drugs, namely pharmaceutical preparations for the central nervous system; Peripheral nerve drugs, namely pharmaceutical agents affecting peripheral nervous system; Drugs affecting sensory organs, namely pharmaceutical agents affecting sensory organs; Antiallergic drugs, namely pharmaceutical antiallergic preparations and substances; Cardiovascular drugs, namely cardiovascular preparations; Drugs affecting respiratory organs, namely pharmaceutical preparations for treating respiratory diseases; Drugs affecting digestive organs, namely pharmaceutical preparations affecting digestive organs; Drugs for outer skin, namely pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of Metabolic disorders; Cellular function activating drugs for medical purposes; Pharmaceutical preparations for suppressing tumors; diagnostic preparations for medical purposes; Pharmaceutical preparations using synthesized peptides used in drug discovery and pharmaceuticals for medical purposes; Synthesized proteins and chemical preparations used in drug discovery and pharmaceuticals for medical purposes |
| Goods and Services | Retail and wholesale store services featuring chemicals; Retail and wholesale store services featuring pharmaceuticals and medical supplements |
| Goods and Services | Chemicals for the manufacture of pharmaceuticals; peptides for scientific and research use; Reagents for biological and chemical purposes and for research purposes, excluding those for medical or veterinary use; Proteins and peptides used in the research and the development and manufacture of pharmaceuticals and biologicals; Chemical reagents used for the detection, measurement and identification of genetic materials or compounds, excluding those for medical and veterinary use |
| Goods and Services | Testing, examination, namely, inspection and research services in the field of pharmaceuticals, cosmetics, and foods, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of medical organisms or bacteria, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of chemistry, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of medical care, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of biotechnology, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the identification of hit lead peptides, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the identification of hit-lead compounds, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the analysis and synthesis of peptides, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the analysis and synthesis of proteins, and the provision of information or advice thereto; The generation of a library of peptides and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the fields of pharmaceuticals, cosmetics, foods, medical organisms or bacteria, chemistry, medical care, biotechnology, identification of hit lead peptides, analysis and synthesis of peptides, using automated screening machines and the provision of information or advice thereto; Scientific research in the nature of conduction of clinical trials for others; Quality control of peptides used in drug development; Advice on quality control of peptides used in drug development |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 12, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 12, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 12, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 12, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 12, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PeptiDream Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Kawasaki-Shi, Kanagawa 210-0821 JP |
| Event Date | Event Description |
| Tuesday, May 16, 2023 | NEW APPLICATION ENTERED |
| Monday, June 12, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 6, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, February 7, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 7, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, February 8, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, February 8, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, February 8, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, May 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 18, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 19, 2024 | ASSIGNED TO LIE |
| Tuesday, September 24, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 24, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 24, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |